Maria Charlotte Fribert
Vorstandsvorsitzender bei TOLERANZIA AB
Profil
Maria Charlotte Fribert is the founder of Epixis SA. She is currently the Chief Executive Officer at Toleranzia AB since 2016.
Previously, she worked at AstraZeneca R&D Mölndal as a Project Director-Drug Development.
Dr. Fribert holds a doctorate degree from Université Pierre et Marie Curie.
Aktive Positionen von Maria Charlotte Fribert
| Unternehmen | Position | Beginn |
|---|---|---|
| TOLERANZIA AB | Vorstandsvorsitzender | 11.04.2016 |
Ehemalige bekannte Positionen von Maria Charlotte Fribert
| Unternehmen | Position | Ende |
|---|---|---|
Epixis SA
 Epixis SA BiotechnologyHealth Technology Epixis SA is a biotechnology company that develops platform for preventive and therapeutic vaccines based on VLPs ('virus-like particles'). It manufactures seasonal or pandemic flu vaccines, to treat Hepatitis C, and to be applied to other infectious diseases, such as Human papillomavirus (HPV) or Human immunodeficiency virus (HIV). The company was incorporated in 2003 and is headquartered in Paris, Frace. | Gründer | - |
| AstraZeneca R&D Mölndal | Corporate Officer/Principal | - |
Ausbildung von Maria Charlotte Fribert
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| TOLERANZIA AB | Health Technology |
| Private Unternehmen | 3 |
|---|---|
| Université Pierre et Marie Curie | Consumer Services |
| AstraZeneca R&D Mölndal | |
Epixis SA
Epixis SA BiotechnologyHealth Technology Epixis SA is a biotechnology company that develops platform for preventive and therapeutic vaccines based on VLPs ('virus-like particles'). It manufactures seasonal or pandemic flu vaccines, to treat Hepatitis C, and to be applied to other infectious diseases, such as Human papillomavirus (HPV) or Human immunodeficiency virus (HIV). The company was incorporated in 2003 and is headquartered in Paris, Frace. | Health Technology |
